Background: Molecular testing (MT) is emerging as a potential prognostic factor that can be
available before treatment of differentiated thyroid carcinoma begins. Among patients …

Purpose: Patients with aggressive thyroid cancer are frequently failed by the central therapy
of ablative radioiodide (RAI) uptake, due to reduced plasma membrane (PM) localization of …

Objective This study aimed to elucidate the underlying mechanisms of ameloblastoma (AM)
through integrated bioinformatics analysis. Methods We downloaded two microarrays of …

Objective To investigate the effect and clinical significance of Delphian lymph nodes (DLN)
on the factors influencing papillary thyroid cancer (PTC) to provide individualized guidance …

The roles and mechanisms of long non-coding RNAs (lncRNAs) in papillary thyroid cancer
(PTC) remain elusive. We obtained RNA sequencing (RNA-seq) data of surgical PTC …

Although papillary thyroid cancer (PTC) has a good prognosis, its recurrence rate is high
and remains a core concern in the clinic. Molecular factors contributing to different …

The introduction and generalization of next-generation sequencing techniques have
significantly increased the identification of mutations in thyroid tumors from multiple patient …

Papillary thyroid carcinoma (PTC) is considered an indolent neoplasm but it may
demonstrate aggressive behavior. We aimed to identify clinical and pathological …

Objectives: Outline the epidemiology and risk factors of thyroid cancer. Describe the clinical
presentation and detailed histopathology of the different types of thyroid cancer. Explain the …

Purpose Although angiogenesis is crucial for the occurrence and development of solid
tumors, the prognostic value of vascularity remains unclear in papillary thyroid cancer (PTC) …